Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Jaume Capdevila
26 years of experience
accreditations :
Clinic is certified :
| Turkey | Austria | Spain | |
| Removal of liver cancer | from $10,800 | from $40,000 | from $35,000 |
| SIRT therapy | from $24,000 | from $17,000 | from $32,000 |
| Liver resection | from $15,950 | from $35,000 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Removal of liver cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Removal of liver cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Removal of liver cancer journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Operation
Day 4 - Post-Operation
Day 5 to Day 14 - Recovery in the Hospital
Week 3 to Week 8 - Rehabilitation at Home
Please note that this is a general guide, individual cases may vary.
Dr. Lana Bijelic specializes in peritoneal carcinomatosis and liver cancer surgery at Centro Médico Teknon. She trained under Prof. Paul Sugarbaker in the US.
Dr. Jaume Capdevila is a highly qualified digestive and pancreatic cancer doctor, holding a degree in Medicine and Surgery from the University of Lleida and a specialization in Medical Oncology from Santa Creu i Sant Pau Hospital. He is a member of several professional organizations, including EORTC, ESMO, ENETS, ASCO, GEMCAD, TTD, and GETHI.
Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.
Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.